Literature DB >> 30249464

Notch signaling regulates cell density-dependent apoptosis of NIH 3T3 through an IL-6/STAT3 dependent mechanism.

Yosuke Matsuno1, Takumi Kiwamoto2, Yuko Morishima2, Yukio Ishii2, Nobuyuki Hizawa2, Cory M Hogaboam3.   

Abstract

Apoptosis is a physiological process that plays a critical maintenance role in cellular homeostasis. Previous reports have demonstrated that cells undergo apoptosis in a cell density-dependent manner, which is regulated, in part, by signal transducers and activators of transcription (STAT) 3. The molecular mechanisms regulating cell density-dependent apoptosis, however, has not been thoroughly investigated to date. Since Notch signaling is activated via direct cell-to-cell contact and plays a pivotal role in cell fate decisions, we examined the role of Notch signaling in cell density-dependent apoptosis of mouse embryonic fibroblasts NIH 3T3 cells. With the increase in cell density, IL-6 expression was induced, which was necessary for STAT3 activation as well as apoptosis regulation. Notch signaling was also activated in a cell-density dependent manner. Blocking Notch signaling either through siRNA-mediated targeting of Jagged1 expression or γ-secretase inhibitor treatment demonstrated that Notch signaling activation was necessary for IL-6 induction. Constitutive activation of Notch signaling via the overexpression of Notch1 intracellular domain was sufficient for the induction of IL-6, which was mediated via direct transcriptional activation. Taken together, our study indicates that Notch signaling regulates cell density-dependent apoptosis through IL-6/STAT3-dependent mechanism. Consequently, Notch signaling might represent a novel therapeutic target in diseases characterized by dysregulated apoptosis.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cell density; IL-6; Notch signaling; STAT3

Mesh:

Substances:

Year:  2018        PMID: 30249464      PMCID: PMC6234060          DOI: 10.1016/j.ejcb.2018.09.001

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  42 in total

Review 1.  Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis.

Authors:  Alexis Desmoulière; Ian A Darby; Giulio Gabbiani
Journal:  Lab Invest       Date:  2003-12       Impact factor: 5.662

2.  Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling.

Authors:  Sachiko Kamakura; Koji Oishi; Takeshi Yoshimatsu; Masato Nakafuku; Norihisa Masuyama; Yukiko Gotoh
Journal:  Nat Cell Biol       Date:  2004-05-23       Impact factor: 28.824

3.  Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression.

Authors:  Michela Noseda; Linda Chang; Graeme McLean; Jonathan E Grim; Bruce E Clurman; Laura L Smith; Aly Karsan
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

4.  Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands.

Authors:  Pingyan Cheng; Yulia Nefedova; Cesar A Corzo; Dmitry I Gabrilovich
Journal:  Blood       Date:  2006-09-14       Impact factor: 22.113

5.  STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma.

Authors:  A Horiguchi; T Asano; K Kuroda; A Sato; J Asakuma; K Ito; M Hayakawa; M Sumitomo; T Asano
Journal:  Br J Cancer       Date:  2010-05-11       Impact factor: 7.640

6.  Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor.

Authors:  Jeffrey C Horowitz; Daniel Y Lee; Meghna Waghray; Venkateshwar G Keshamouni; Peedikayil E Thomas; Hengmin Zhang; Zongbin Cui; Victor J Thannickal
Journal:  J Biol Chem       Date:  2003-10-23       Impact factor: 5.157

Review 7.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

8.  Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1.

Authors:  Y Shen; G Devgan; J E Darnell; J F Bromberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

9.  Inhibition of fibroblast growth by Notch1 signaling is mediated by induction of Wnt11-dependent WISP-1.

Authors:  Zhao-Jun Liu; Yan Li; Yurong Tan; Min Xiao; Jialin Zhang; Freddy Radtke; Omaida C Velazquez
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

10.  Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation.

Authors:  Maria-Giuseppina Procopio; Csaba Laszlo; Dania Al Labban; Dong Eun Kim; Pino Bordignon; Seung-Hee Jo; Sandro Goruppi; Elena Menietti; Paola Ostano; Ugo Ala; Paolo Provero; Wolfram Hoetzenecker; Victor Neel; Witold W Kilarski; Melody A Swartz; Cathrin Brisken; Karine Lefort; G Paolo Dotto
Journal:  Nat Cell Biol       Date:  2015-08-24       Impact factor: 28.824

View more
  3 in total

1.  [Inhibition of the Notch1/Jagged1 pathway promotes homing of bone mesenchymal stem cells to improve asthma in rats].

Authors:  K Wang; H Zhu; L Yang; Q Xu; F Ren; X Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-10-20

2.  Introduction of a plasmid and a protein into bovine and swine cells by water-in-oil droplet electroporation.

Authors:  Takeshi Ishino; Hirofumi Kurita; Rikio Kirisawa; Yoshinori Shimamoto; Rika Numano; Hiroshi Kitamura
Journal:  J Vet Med Sci       Date:  2019-11-27       Impact factor: 1.267

3.  Punicalagin Alleviates Aged Bronchial Asthma by Inhibiting Th2 Differentiation through IL-4/STAT6 and Jagged1/Notch Pathways.

Authors:  Li Yu; Jianying Li
Journal:  J Healthc Eng       Date:  2022-01-30       Impact factor: 2.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.